Verastem Price To Sales Ratio vs Ev To Sales Analysis

VSTM Stock

USD 4.00 0.07 1.78%

Verastem financial indicator trend analysis is much more than just breaking down Verastem prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Verastem is a good investment. Please check the relationship between Verastem Price To Sales Ratio and its Ev To Sales accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.

Price To Sales Ratio vs Ev To Sales

Price To Sales Ratio vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Verastem Price To Sales Ratio account and Ev To Sales. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Verastem's Price To Sales Ratio and Ev To Sales is 0.98. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Verastem, assuming nothing else is changed. The correlation between historical values of Verastem's Price To Sales Ratio and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Verastem are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Price To Sales Ratio i.e., Verastem's Price To Sales Ratio and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Verastem stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Verastem sales, a figure that is much harder to manipulate than other Verastem multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Verastem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Verastem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.At this time, Verastem's Selling General Administrative is very stable compared to the past year. As of the 24th of November 2024, Issuance Of Capital Stock is likely to grow to about 125.5 M, while Sales General And Administrative To Revenue is likely to drop 2.31.

Verastem fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Net Tangible Assets
Total Assets		0.68	0.81	0.59	0.64	0.66	0.28	0.44	0.7	0.22	0.26	0.52	0.28	0.16	-0.41	0.28	0.16	0.17	0.92	0.3	0.7	0.38	0.52	0.14	0.93	0.01
Other Current Liab	0.68		0.71	0.51	0.38	0.79	0.63	0.65	0.35	0.56	0.04	0.65	-0.04	-0.35	-0.69	-0.37	-0.28	-0.28	0.81	0.67	0.48	0.07	0.8	0.26	0.82	0.09
Total Current Liabilities	0.81	0.71		0.19	0.83	0.72	0.5	0.63	0.81	0.43	-0.02	0.72	0.37	0.2	-0.7	0.23	0.43	0.39	0.73	0.53	0.31	0.52	0.77	0.5	0.76	-0.46
Total Stockholder Equity	0.59	0.51	0.19		0.01	0.44	0.08	0.15	-0.16	0.2	0.46	-0.03	0.0	-0.37	-0.1	-0.16	-0.43	-0.35	0.63	0.13	0.77	-0.44	0.27	-0.14	0.62	0.57
Accounts Payable	0.64	0.38	0.83	0.01		0.55	0.18	0.25	0.76	0.01	-0.07	0.35	0.29	0.29	-0.39	0.31	0.48	0.39	0.52	0.17	0.04	0.52	0.42	0.3	0.54	-0.59
Cash	0.66	0.79	0.72	0.44	0.55		0.42	0.47	0.41	0.46	0.11	0.57	0.07	-0.49	-0.56	-0.27	-0.08	-0.1	0.74	0.47	0.48	0.13	0.66	0.35	0.75	0.0
Common Stock Shares Outstanding	0.28	0.63	0.5	0.08	0.18	0.42		0.93	0.21	0.44	-0.32	0.52	0.1	-0.18	-0.94	-0.21	0.05	-0.04	0.31	0.99	0.1	0.02	0.79	0.47	0.34	-0.32
Other Current Assets	0.44	0.65	0.63	0.15	0.25	0.47	0.93		0.37	0.58	-0.12	0.63	0.3	-0.05	-0.95	-0.02	0.2	0.2	0.43	0.95	0.17	0.16	0.86	0.43	0.46	-0.31
Total Liab	0.7	0.35	0.81	-0.16	0.76	0.41	0.21	0.37		0.12	-0.06	0.64	0.37	0.54	-0.36	0.51	0.58	0.55	0.55	0.2	0.18	0.86	0.35	0.27	0.58	-0.46
Common Stock	0.22	0.56	0.43	0.2	0.01	0.46	0.44	0.58	0.12		0.07	0.51	0.2	-0.27	-0.6	-0.15	0.03	0.15	0.21	0.56	0.05	-0.09	0.72	0.46	0.23	-0.08
Property Plant Equipment	0.26	0.04	-0.02	0.46	-0.07	0.11	-0.32	-0.12	-0.06	0.07		0.09	0.58	-0.09	0.22	-0.08	-0.1	0.12	0.25	-0.27	0.34	-0.2	-0.03	-0.21	0.24	0.37
Other Liab	0.52	0.65	0.72	-0.03	0.35	0.57	0.52	0.63	0.64	0.51	0.09		0.4	0.06	-0.63	-0.01	0.27	0.27	0.56	0.55	0.3	0.54	0.68	0.55	0.59	-0.26
Property Plant And Equipment Net	0.28	-0.04	0.37	0.0	0.29	0.07	0.1	0.3	0.37	0.2	0.58	0.4		0.39	-0.27	0.37	0.6	0.71	0.12	0.13	0.0	0.24	0.29	0.32	0.15	-0.41
Net Debt	0.16	-0.35	0.2	-0.37	0.29	-0.49	-0.18	-0.05	0.54	-0.27	-0.09	0.06	0.39		0.12	0.83	0.67	0.67	-0.07	-0.22	-0.17	0.64	-0.19	-0.02	-0.05	-0.46
Retained Earnings	-0.41	-0.69	-0.7	-0.1	-0.39	-0.56	-0.94	-0.95	-0.36	-0.6	0.22	-0.63	-0.27	0.12		0.1	-0.23	-0.17	-0.39	-0.96	-0.08	-0.11	-0.93	-0.6	-0.42	0.47
Non Current Assets Total	0.28	-0.37	0.23	-0.16	0.31	-0.27	-0.21	-0.02	0.51	-0.15	-0.08	-0.01	0.37	0.83	0.1		0.76	0.76	-0.03	-0.22	0.03	0.53	-0.13	0.09	-0.01	-0.4
Non Currrent Assets Other	0.16	-0.28	0.43	-0.43	0.48	-0.08	0.05	0.2	0.58	0.03	-0.1	0.27	0.6	0.67	-0.23	0.76		0.95	-0.12	0.05	-0.19	0.54	0.18	0.5	-0.08	-0.78
Other Assets	0.17	-0.28	0.39	-0.35	0.39	-0.1	-0.04	0.2	0.55	0.15	0.12	0.27	0.71	0.67	-0.17	0.76	0.95		-0.1	-0.01	-0.17	0.52	0.17	0.36	-0.06	-0.65
Cash And Short Term Investments	0.92	0.81	0.73	0.63	0.52	0.74	0.31	0.43	0.55	0.21	0.25	0.56	0.12	-0.07	-0.39	-0.03	-0.12	-0.1		0.33	0.76	0.33	0.5	0.02	1.0	0.22
Common Stock Total Equity	0.3	0.67	0.53	0.13	0.17	0.47	0.99	0.95	0.2	0.56	-0.27	0.55	0.13	-0.22	-0.96	-0.22	0.05	-0.01	0.33		0.1	-0.02	0.85	0.5	0.36	-0.3
Short Term Investments	0.7	0.48	0.31	0.77	0.04	0.48	0.1	0.17	0.18	0.05	0.34	0.3	0.0	-0.17	-0.08	0.03	-0.19	-0.17	0.76	0.1		0.03	0.2	-0.02	0.75	0.53
Non Current Liabilities Total	0.38	0.07	0.52	-0.44	0.52	0.13	0.02	0.16	0.86	-0.09	-0.2	0.54	0.24	0.64	-0.11	0.53	0.54	0.52	0.33	-0.02	0.03		0.03	0.08	0.35	-0.38
Other Stockholder Equity	0.52	0.8	0.77	0.27	0.42	0.66	0.79	0.86	0.35	0.72	-0.03	0.68	0.29	-0.19	-0.93	-0.13	0.18	0.17	0.5	0.85	0.2	0.03		0.6	0.53	-0.36
Property Plant And Equipment Gross	0.14	0.26	0.5	-0.14	0.3	0.35	0.47	0.43	0.27	0.46	-0.21	0.55	0.32	-0.02	-0.6	0.09	0.5	0.36	0.02	0.5	-0.02	0.08	0.6		0.06	-0.62
Total Current Assets	0.93	0.82	0.76	0.62	0.54	0.75	0.34	0.46	0.58	0.23	0.24	0.59	0.15	-0.05	-0.42	-0.01	-0.08	-0.06	1.0	0.36	0.75	0.35	0.53	0.06		0.17
Net Tangible Assets	0.01	0.09	-0.46	0.57	-0.59	0.0	-0.32	-0.31	-0.46	-0.08	0.37	-0.26	-0.41	-0.46	0.47	-0.4	-0.78	-0.65	0.22	-0.3	0.53	-0.38	-0.36	-0.62	0.17

Click cells to compare fundamentals

Verastem Account Relationship Matchups

Verastem fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	145.0M	154.3M	108.7M	95.1M	149.7M	125.4M
Other Current Liab	450K	14.1M	15.0M	15.0M	17.3M	9.1M
Total Current Liabilities	29.9M	17.1M	18.6M	21.7M	26.4M	16.6M
Total Stockholder Equity	7.2M	115.3M	87.6M	47.4M	57.4M	75.3M
Accounts Payable	9.7M	1.9M	2.3M	4.9M	7.2M	5.0M
Cash	43.5M	67.8M	100.3M	74.9M	78.8M	63.4M
Common Stock Shares Outstanding	6.2M	12.8M	14.5M	16.1M	22.1M	23.2M
Other Current Assets	3.8M	6.9M	5.0M	4.9M	6.6M	6.9M
Total Liab	137.9M	39.1M	21.1M	47.7M	71.2M	48.4M
Common Stock	7K	8K	17K	19K	20K	2.9K
Property Plant Equipment	947K	3.1M	210K	92K	105.8K	100.5K
Property Plant And Equipment Net	4.0M	3.1M	210K	1.9M	1.2M	1.8M
Net Debt	64.0M	(45.2M)	(98.0M)	(47.9M)	(36.4M)	(38.2M)
Retained Earnings	(524.8M)	(592.5M)	(663.7M)	(737.5M)	(824.9M)	(783.6M)
Non Current Assets Total	60.1M	9.4M	2.9M	2.2M	6.0M	11.4M
Non Currrent Assets Other	36.1M	274K	2.5M	58K	4.6M	4.2M
Other Assets	36.1M	9.0M	410K	299K	343.9K	326.7K
Cash And Short Term Investments	75.5M	141.2M	100.3M	87.9M	137.1M	115.7M
Common Stock Total Equity	8K	17K	19K	20K	23K	24.2K
Short Term Investments	32.0M	73.4M	79.0M	13.0M	59.2M	61.7M
Liabilities And Stockholders Equity	145.0M	154.3M	108.7M	95.1M	149.7M	134.7M
Non Current Liabilities Total	108.0M	22.0M	2.5M	26.0M	44.8M	34.2M
Other Stockholder Equity	531.9M	707.7M	751.2M	784.9M	861.1M	468.2M
Property Plant And Equipment Gross	4.0M	416K	4.2M	3.4M	2.8M	2.2M
Total Current Assets	85.0M	144.9M	105.7M	92.9M	143.7M	119.1M
Accumulated Other Comprehensive Income	14K	53K	34K	13K	15.0K	15.7K
Net Tangible Assets	(12.8M)	115.3M	87.6M	47.4M	42.7M	63.3M
Long Term Debt	103.6M	19.1M	249K	24.5M	40.1M	29.1M
Net Receivables	2.5M	239K	516K	31K	42K	39.9K
Retained Earnings Total Equity	(524.8M)	(592.5M)	(663.7M)	(737.5M)	(663.8M)	(630.6M)
Capital Surpluse	531.9M	707.7M	751.2M	784.9M	902.6M	481.7M
Non Current Liabilities Other	4.4M	2.9M	2.3M	1.5M	1.7M	1.4M
Short Long Term Debt Total	107.5M	22.5M	2.3M	27.1M	41.6M	38.4M
Long Term Debt Total	103.6M	19.1M	249K	24.5M	22.1M	36.9M
Net Invested Capital	110.8M	134.3M	87.8M	72.2M	97.5M	93.7M
Net Working Capital	55.1M	127.8M	87.2M	71.2M	117.3M	85.2M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:

How To Invest In Verastem

Details

Is Verastem Stock a good investment?

Details

What is Verastem's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.

You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.14)

Revenue Per Share

0.331

Quarterly Revenue Growth

(1.00)

Return On Assets

(0.47)

Return On Equity

(1.37)

The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Verastem Price To Sales Ratio vs Ev To Sales Analysis

Price To Sales Ratio vs Ev To Sales

Price To Sales Ratio vs Ev To Sales Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Ev To Sales

Verastem fundamental ratios Correlations

Verastem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Verastem fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.95	Other Current Assets
Other Assets	+ 0.95	Non Currrent Assets Other
Total Current Assets	+ 0.93	Total Assets
Other Current Assets	+ 0.93	Common Stock Shares Outstanding

Common Stock Total Equity	- 0.96	Retained Earnings
Retained Earnings	- 0.95	Other Current Assets
Retained Earnings	- 0.94	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.93	Retained Earnings
Net Tangible Assets	- 0.78	Non Currrent Assets Other
Retained Earnings	- 0.7	Total Current Liabilities